The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Effects of Aldosterone on the Vasculature
Abstract
Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally published in Hypertension can be obtained via RightsLink, a service of the Copyright Clearance Center, not the Editorial Office. Once the online version of the published article for which permission is being requested is located, click Request Permissions in the middle column of the Web page under Services. Further information about this process is available in the Permissions and Rights Question and Answer document. Reprints: Information about reprints can be found online at:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Pitt, B., Wj, R., Zannad, F. M., Neaton, J. D., Martínez, F. A., Roniker, B., Bittman, R. M., Hurley, S., Kleiman, J. H., & Gatlin, M. R. (2003) · Cited by 708
Nongenomic steroid action: controversies, questions, and answers
LÖSEL, R. M., FALKENSTEIN, E., FEURING, M., SCHULTZ, A., TILLMANN, H.-C., ROSSOL-HASEROTH, K., & WEHLING, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00003.2003 · Cited by 561
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
Blasi, E. R., Rocha, R., Rudolph, A. E., Blomme, E. A. G., Polly, M. L., & McMahon, E. G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00929.x · Cited by 542
Farquharson, C. A. J., & Struthers, A. D. (2000) · Circulation · doi:10.1161/01.cir.101.6.594 · Cited by 532
Diuretic Therapy for Hypertension and the Risk of Primary Cardiac Arrest
Siscovick, D. S., Raghunathan, T. E., Psaty, B. M., Koepsell, T. D., Wicklund, K. G., Lin, X., Cobb, L., Rautaharju, P. M., Copass, M. K., & Wagner, E. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302603 · Cited by 434
Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress
Virdis, A., Neves, M. F., Amiri, F., Viel, E., Touyz, R. M., & Schiffrin, E. L. (2002) · Hypertension · doi:10.1161/01.hyp.0000034738.79310.06 · Cited by 399
Self-citationSilvestre, J.-S., Heymes, C., Oubénaïssa, A., Robert, V., Aupetit-Faisant, B., Carayon, A., Swynghedauw, B., & Delcayre, C. (1999) · Circulation · doi:10.1161/01.cir.99.20.2694 · Cited by 380
Jaffe, I. Z., & Mendelsohn, M. E. (2005) · Circulation Research · doi:10.1161/01.res.0000159937.05502.d1 · Cited by 358
Mechanisms of Mineralocorticoid Action
Fuller, P. J., & Young, M. J. (2005) · Hypertension · doi:10.1161/01.hyp.0000193502.77417.17 · Cited by 329
Hatakeyama, H., Miyamori, I., Fujita, T., Takeda, Y., Takeda, R., & Yamamoto, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51084-5 · Cited by 316
Role of Aldosterone in Renal Vascular Injury in Stroke-Prone Hypertensive Rats
Rocha, R., Chander, P. N., Zuckerman, A., & Stier, C. T. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.232 · Cited by 310
Rocha, R., Martin-Berger, C. L., Yang, P., Scherrer, R., Delyani, J., & McMahon, E. (2002) · Endocrinology · doi:10.1210/en.2002-220120 · Cited by 308
Larivière, R., Thibault, G., & Schiffrin, E. L. (1993) · Hypertension · doi:10.1161/01.hyp.21.3.294 · Cited by 282
Self-citationEndothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling
Pu, Q., Neves, M. F., Virdis, A., Touyz, R. M., & Schiffrin, E. L. (2003) · Hypertension · doi:10.1161/01.hyp.0000078357.92682.ec · Cited by 255
Self-citationAldosterone Activates Vascular p38MAP Kinase and NADPH Oxidase Via c-Src
Callera, G. E., Touyz, R. M., Tostes, R. C., Yogi, A., He, Y., Malkinson, S., & Schiffrin, E. L. (2005) · Hypertension · doi:10.1161/01.hyp.0000154365.30593.d3 · Cited by 246
Self-citationKeidar, S., Kaplan, M., Pavlotzky, E., Coleman, R., Hayek, T., Hamoud, S., & Aviram, M. (2004) · Circulation · doi:10.1161/01.cir.0000127949.05756.9d · Cited by 244
Structural remodeling in hypertensive heart disease and the role of hormones.
Weber, K. T., Sun, Y., & Guarda, E. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.869 · Cited by 230
Mineralocorticoid Receptor Antagonism in Experimental Atherosclerosis
Rajagopalan, S., Duquaine, D., King, S., Pitt, B., & Patel, P. (2002) · Circulation · doi:10.1161/01.cir.0000015854.60710.10 · Cited by 223
Aldosterone Potentiates Angiotensin II–Induced Signaling in Vascular Smooth Muscle Cells
Mazak, I., Fiebeler, A., Muller, D. N., Park, J.-K., Shagdarsuren, E., Lindschau, C., Dechend, R., Viedt, C., Pilz, B., Haller, H., et al. (2004) · Circulation · doi:10.1161/01.cir.0000131860.80444.ab · Cited by 218
Suzuki, G., Morita, H., Mishima, T., Sharov, V. G., Todor, A., Tanhehco, E. J., Rudolph, A. E., McMahon, E. G., Goldstein, S., & Sabbah, H. N. (2002) · Circulation · doi:10.1161/01.cir.0000039104.56479.42 · Cited by 218
Fiebeler, A., Schmidt, F., Müller, D. N., Park, J.-K., Dechend, R., Bieringer, M., Shagdarsuren, E., Breu, V., Haller, H., & Luft, F. C. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.787 · Cited by 213
Harada, E., Yoshimura, M., Yasue, H., Nakagawa, O., Nakagawa, M., Harada, M., Mizuno, Y., Nakayama, M., Shimasaki, Y., Ito, T., et al. (2001) · Circulation · doi:10.1161/01.cir.104.2.137 · Cited by 211
Nongenomic Vascular Action of Aldosterone in the Glomerular Microcirculation
Arima, S., Kohagura, K., Xu, H.-L., Sugawara, A., Abe, T., Satoh, F., Takeuchi, K., & Ito, S. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000083982.74108.54 · Cited by 202
Nongenomic Effects of Aldosterone on Intracellular Ca2+in Vascular Smooth Muscle Cells
Wehling, M., Neylon, C. B., Fullerton, M., Bobik, A., & Funder, J. W. (1995) · Circulation Research · doi:10.1161/01.res.76.6.973 · Cited by 190
Iglarz, M., Touyz, R. M., Viel, É. C., Amiri, F., & Schiffrin, E. L. (2004) · American Journal of Hypertension · doi:10.1016/s0895-7061(04)00811-8 · Cited by 172
Self-citationMin, L.-J., Mogi, M., Li, J.-M., Iwanami, J., Iwai, M., & Horiuchi, M. (2005) · Circulation Research · doi:10.1161/01.res.0000180753.63183.95 · Cited by 170
Production of Aldosterone in Isolated Rat Blood Vessels
Takeda, Y., Miyamori, I., Yoneda, T., Iki, K., Hatakeyama, H., Blair, I. A., Hsieh, F.-Y., & Takeda, R. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.170 · Cited by 168
Liu, S. L., Schmuck, S., Chorazcyzewski, J. Z., Gros, R., & Feldman, R. D. (2003) · Circulation · doi:10.1161/01.cir.0000093188.53554.44 · Cited by 164
Ammarguellat, F., Gannon, P. O., Amiri, F., & Schiffrin, E. L. (2002) · Hypertension · doi:10.1161/hy0202.103481 · Cited by 163
Self-citationIglarz, M., Touyz, R. M., Viel, É. C., Amiri, F., & Schiffrin, E. L. (2004) · PubMed · Cited by 158
Self-citationVASCULAR TYPE I ALDOSTERONE BINDING SITES ARE PHYSIOLOGICAL MINERALOCORTICOID RECEPTORS
Funder, J. W., Pearce, P., Smith, R., & Campbell, J. H. (1989) · Endocrinology · doi:10.1210/endo-125-4-2224 · Cited by 144
Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses.
Ullian, M. E., Schelling, J. R., & Linas, S. L. (1992) · Hypertension · doi:10.1161/01.hyp.20.1.67 · Cited by 141
Human Endothelium: Target for Aldosterone
Oberleithner, H., Ludwig, T. E., Riethmüller, C., Hillebrand, U., Albermann, L., Schäfer, C., Shahin, V., & Schillers, H. (2004) · Hypertension · doi:10.1161/01.hyp.0000123572.45556.a5 · Cited by 139
Origin of Aldosterone in the Rat Heart
Gómez-Sánchez, E. P., Ahmad, N., Romero, D. G., & Gómez-Sánchez, C. E. (2004) · Endocrinology · doi:10.1210/en.2004-0295 · Cited by 136
Cardiac Damage Prevention by Eplerenone: Comparison With Low Sodium Diet or Potassium Loading
Martinez-Vasquez, D., Rocha, R., Matsumura, M., Oestreicher, E. M., Ochoa-Maya, M. R., Roubsanthisuk, W., Williams, G. H., & Adler, G. K. (2002) · Hypertension · doi:10.1161/hyp.39.2.614 · Cited by 134
Keidar, S., Hayek, T., Kaplan, M., Pavlotzky, E., Hamoud, S., Coleman, R., & Aviram, M. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200306000-00019 · Cited by 130
Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1
Park, J. B., & Schiffrin, E. L. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02291-9 · Cited by 127
Self-citationBlanco‐Rivero, J., Cachofeiro, V., Lahera, V., Aras‐López, R., Márquez‐Rodas, I., Salaíces, M., Xavier, F. E., Ferrer, M., & Balfagón, G. (2005) · Hypertension · doi:10.1161/01.hyp.0000171479.36880.17 · Cited by 126
Garnier, A., Bendall, J. K., Fuchs, S., Escoubet, B., Rochais, F., Hoerter, J. A., Nehmé, J., Ambroisine, M.-L., Angelis, N. D., Morineau, G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000142858.44680.27 · Cited by 125
Cardiac aldosterone production and ventricular remodeling
Delcayre, C., Silvestre, J., Garnier, A., Oubénaı̈ssa, A., Cailmail, S., Tatara, E., Bernard Swynghedauw, A., & Robert, V. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00973.x · Cited by 123
Increasing the Dietary Potassium Intake Reduces the Need for Antihypertensive Medication
Siani, A., Strazzullo, P., Giacco, A., Pacioni, D., Celentano, E., & Mancini, M. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-10-753 · Cited by 123
Rapid Nongenomic Effects of Aldosterone on Human Forearm Vasculature
Schmidt, B. M. W., Oehmer, S., Delles, C., Bratke, R., Schneider, M. P., Klingbeil, A. U., Fleischmann, E. H., & Schmieder, R. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000083298.23119.16 · Cited by 120
Park, J. B., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/01.hyp.37.6.1444 · Cited by 119
Self-citationRenoprotection by ACE Inhibition or Aldosterone Blockade Is Blood Pressure–Dependent
Griffin, K. A., Abu‐Amarah, I., Picken, M. M., & BIDANI, A. K. (2003) · Hypertension · doi:10.1161/01.hyp.0000049881.25304.73 · Cited by 117
Endemann, D., Touyz, R. M., Iglarz, M., Savoia, C., & Schiffrin, E. L. (2004) · Hypertension · doi:10.1161/01.hyp.0000128031.31572.a3 · Cited by 109
Self-citationKobayashi, N., Hara, K., Tojo, A., Onozato, M. L., Honda, T., Yoshida, K., Mita, S.-I., Nakano, S., Tsubokou, Y., & Matsuoka, H. (2005) · Hypertension · doi:10.1161/01.hyp.0000157408.43807.5a · Cited by 102
Nongenomic Effects of Aldosterone in the Human Heart: Interaction With Angiotensin II
Chai, W., Garrelds, I. M., VRIES, R. D., Batenburg, W. W., van Kats, J. P., & Danser, A. H. J. (2005) · Hypertension · doi:10.1161/01.hyp.0000182661.98259.4f · Cited by 100
Aldosterone makes human endothelium stiff and vulnerable
Oberleithner, H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00263.x · Cited by 97
Christ, M., Guenther, A., Heck, M., Schmidt, B. M. W., Falkenstein, E., & Wehling, M. (1999) · Circulation · doi:10.1161/01.cir.99.11.1485 · Cited by 95
Endothelium-Derived Nitric Oxide Modulates Vascular Action of Aldosterone in Renal Arteriole
Arima, S., Kohagura, K., Xu, H.-L., Sugawara, A., Uruno, A., Satoh, F., Takeuchi, K., & Ito, S. (2003) · Hypertension · doi:10.1161/01.hyp.0000111138.78714.1a · Cited by 91
Eplerenone Inhibits Atherosclerosis in Nonhuman Primates
Takai, S., Jin, D., Muramatsu, M., Kirimura, K., Sakonjo, H., & Miyazaki, M. (2005) · Hypertension · doi:10.1161/01.hyp.0000184640.81730.22 · Cited by 91
Ishizawa, K., Izawa, Y., Ito, H., Miki, C., Miyata, K., Fujita, Y., Kanematsu, Y., Tsuchiya, K., Tamaki, T., Nishiyama, A., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000172622.51973.f5 · Cited by 88
Ebata, S., Muto, S., Okada, K., Nemoto, J., Amemiya, M., Saito, T., & Asano, Y. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00674.x · Cited by 86
Schiffrin, E. L., Gutkowska, J., & Genest, J. (1984) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1984.246.4.h608 · Cited by 86
Self-citationAldosterone Enhances Ischemia-Induced Neovascularization Through Angiotensin II–Dependent Pathway
Michel, F. S., Ambroisine, M.-L., Duriez, M., Delcayre, C., Levy, B. I., & Silvestre, J. (2004) · Circulation · doi:10.1161/01.cir.0000127112.36796.9b · Cited by 85
Xiao, F., Puddefoot, J. R., Barker, S., & Vinson, G. P. (2004) · Hypertension · doi:10.1161/01.hyp.0000140771.21243.ed · Cited by 84
Ye, P., Kenyon, C. J., MacKenzie, S. M., de Jong, A. S., Miller, C., Gray, G. A., Wallace, A., Ryding, A. S., Mullins, J. J., McBride, M., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0370 · Cited by 55
Fujita, M., Minamino, T., Asanuma, H., Sanada, S., Hirata, A., Wakeno, M., Myoishi, M., Okuda, H., Ogai, A., Okada, K.-I., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000171184.84077.80 · Cited by 51
Honeck, H., Groß, V., Erdmann, B., Kärgel, E., Neunaber, R., Milia, A. F., Schneider, W., Luft, F. C., & Schunck, W. (2000) · Hypertension · doi:10.1161/01.hyp.36.4.610 · Cited by 51
Do Human Vascular Endothelial Cells Produce Aldosterone?
Ahmad, N., Romero, D. G., Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (2004) · Endocrinology · doi:10.1210/en.2004-0081 · Cited by 50
Kambara, A., Holycross, B. J., Wung, P. K., Schanbacher, B. L., Ghosh, S., McCune, S. A., Bauer, J. A., & Kwiatkowski, P. A. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200306000-00002 · Cited by 37
Ullian, M. E., & Fine, J. J. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041610203 · Cited by 37
Rapid aldosterone effects on tyrosine phosphorylation in vascular smooth muscle cells.
Jc, M., Falkenstein, E., Wehling, M., & Christ, M. (1999) · PubMed · Cited by 35
Ma, J., Albornoz, F., Yu, C., Byrne, D. W., Vaughan, D. E., & Brown, N. J. (2005) · Hypertension · doi:10.1161/01.hyp.0000174327.53863.86 · Cited by 34
11β-Hydroxysteroid dehydrogenase in human vascular cells
Hatakeyama, H., Inaba, S., Takeda, R., & Miyamori, I. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00974.x · Cited by 33
Aldosterone and Nuclear Volume Cycling
Oberleithner, H., Reinhardt, J., Schillers, H., Pagel, P., & Schneider, S. W. (2000) · Cellular Physiology and Biochemistry · doi:10.1159/000016379 · Cited by 32
Angiotensin II-aldosterone interactions on protein synthesis in vascular smooth muscle cells
Ullian, M. E., Hutchison, F. N., Hazen‐Martin, D. J., & Morinelli, T. A. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.6.c1525 · Cited by 31
Cardiac Steroidogenesis--New Sites of Synthesis, or Much Ado About Nothing?
Gómez-Sánchez, C. E., & Gómez-Sánchez, E. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8102 · Cited by 28
Cited by
Metabolic syndrome: definitions and controversies
Kassi, E., Pervanidou, P., Kaltsas, G., & Chrousos, G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-48 · Cited by 1,565
“Furthermore, either use of angiotensin II type 1 receptor antagonists or genetic knockout of angiotensin II type 1 receptor are known to effectively attenuate lipid accumulation in the liver [99-105].”
Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L., Kaplan, N. M., O’Connor, C. M., O’Gara, P. T., & Oparil, S. (2007) · Circulation · doi:10.1161/circulationaha.107.183885 · Cited by 757
Plasma sodium stiffens vascular endothelium and reduces nitric oxide release
Oberleithner, H., Riethmüller, C., Schillers, H., MacGregor, G. A., de Wardener, H. E., & Hausberg, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707791104 · Cited by 480
The renin-angiotensin-aldosterone system and its suppression
Ames, M. K., Atkins, C. E., & Pitt, B. (2019) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15454 · Cited by 433
Vascular Endothelial Function and Hypertension: Insights and Directions
Dharmashankar, K., & Widlansky, M. E. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0150-2 · Cited by 424
Metadata
- Authors
- Schiffrin, E. L.
- Venue
- Hypertension
- Published
- 2006-03
- Volume
- 47
- Issue
- 3
- Pages
- 312-318
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2076347631
- Cited by
- 303
- References
- 72
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.